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FINAL REPORT
INVESTIGATION OF THE MEDICAL APPLICATIONS OF THE UNIQUE BIOCARBONS
DEVELOPED BY NASA
INTRODUCTION
Over two and one-half years ago, a proposal was developed at this
facility (Rancho Los Amigos Hospital) to investigate the potential medical
applications of "unique bioCarbons." This project was developed in order
to take advantage of the unusual tissue compatibility characteristics
of pure carbon.
Several basic assumptions were made at the time of the construction
of this proposal: (1) The reactions at tissue interface between the
living system and the prosthetic device is the most important factor
in the successful applications of substitute mechanisms for biologic
systems. (2) Of all tissue reaction locations, the skin interface with
a prosthesis is the most demanding. (3) In that the whole purpose of
our interest in pure carbons is for medical applications, there is no
other experimental model for medical applications of percutaneous devices
than human skin. Thus, all experimental studies would have to be done
on humans. (4) No attempt would be made to develop some new material,
but rather the purpose of the proposal was to utilize commercially
available pure carbons and develop designs which would be applicable for
medical applications.
In that the use of human subjects for trial of carbon devices was
deemed necessary, true medical needs for skin interface challenges were
used. Medically, especially in the environment of an orthopedic
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rehabilitation unit, the most consistent need for percutaneous challenge
is in a skeletal traction. Thus, construction of skeletal traction
devices with carbon interface at the skin was considered the most reasonable
location for prosthetic-human interface challenge. It was hoped that by
constructing carbon devices of various commercially available materials
and using these for a skeletal traction some understanding in the
difference of tissue reaction related to different types of pure carbon
could be understood. Phase I of the proposal was the construction of
carbon traction devices.
A true medical need, but conceptually more advanced than current
medical practice, was the development of a neuroelectric plug-in device.
Currently, a multitude of implanted electrical power systems are being
used and, in addition, there are a multitude of applications of external
neuroelectric stimulation and control. A reliable connect-disconnect
system for electrical communication with internal structures and devices
is considered a significant medical need. Although at the time of the
proposal a specific design for such a device was not at hand, its
potential was recognized.
It was recognized that a significant interface problem exists
between the attachment of a prosthesis and the skeletal structures.
This was also a challenging environment for pure materials and considerd
a reasonable location for testing bioapplications. A bone bridge
experiment was constructed wherein the tissue interface between bone and
prosthetic device would have had to suffer not only the trauma of tissue
reaction to foreign substance, but also the mechanical stresses of
Medical Applications of Unique BioCarbons Page 3.
functional use normal to that location.
Finally, the fourth phase of the proposal was considered the
ultimate application of the entire system - a connect-disconnect system
for a limb prosthesis. This particular problem was the center of
interest of this unit at Rancho Los Amigos Hospital and was considered
the severest challenge of all medical applications for tissue interface
problems. In the scope of the proposal it was not considered that a
truly reliable system could be developed, but rather that the principles
could be sufficiently understood so that a system could be designed
which had the expectation of success.
Since the writing of the original proposal, a number of events
have occurred which have considerably changed the scope of the work done.
The first phase was largely unsuccessful. Although we had tentative
agreement from several colleagues as to the applications of bioCarbon
traction devices, and, indeed, had approximately forty such devices
manufactured in cooperation with Cutter Laboratories, the number of
true human applications was quite small. One reason for this is that
the carbon design with a dacron flange required surgical application
of skeletal traction through a hole measuring approximately 3/4 of an
inch. This is in contrast to the normal skeletal traction systems
wherein a skin perforation under any circumstances would not exceed
3/16 of an inch. There were very few skeletal traction applications
wherein the potential trade-off of infection-free traction passage
was worthy of the larger surgical incision necessary to achieve carbon
utilization. In essence, no reliable data was developed from the
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skeletal traction phase of the project.
On the other hand, the particular design utilized for the skeletal
traction device was applied at this unit for prosthetic suspension.
Two patients had implantation of tubes transversely in their stumps
with the skin interface of the carbon traction device. These patients
had their prosthetic devices suspended by way of this system. Indeed,
this system from a skin interface aspect functioned beautifully. The
successful skin interface aspects of these designs confirmed the medical
applications of pure carbon. Examples of these applications are described
later in the report.
In contrast to the poor result of the Phase I skeletal traction design,
the neuroelectric plug-in system of Phase II progressed rapidly from the
standpoint of concept and human applications. The accompanying paper,
entitled "The Use of Pure Carbon for Permanent Percutaneous Electrical
Connector Systems", which has been accepted for publication in the
Archives of Surgery, outlines our progress and applications in this area.
Although considerable development is still necessary in the engineering
of the plug-in systems, it has been demonstrated to be a reliable device
and represents an excellent example of medical application of Aerospace
Technology which fulfills a true need. Our Final Report largely deals
with examples of this application.
The use of pure carbons at the skeletal interface in the bone bridge
experiment has faded considerably in our interest at the present time.
The bone bridge experiment was undertaken using twelve animals. For
many technical reasons, a successful skeletal interface between prosthetic
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material and the skeletal system was not achieved in any but one type
of system. This system was that of methylmethacrylate bone cement.
Currently, this mode of skeletal fixation of prosthetic devices is
being widely used clinically, and, indeed, with considerable success.
The limitation of carbon as a skeletal interface system basically is
the requirement of bone ingrowth time into the interstices of the carbon
interface. (Figure 1)
Figure 1
Intermedullary bone spaces in femur of dog comparing dacron covered
silastic to set-in-place methylmethacrylate.
At this time, unfortunately, it is clinically unacceptable,
especially when the carbon system competes with, on the whole, an
extremely suscessful system using methylmethacrylate. For the present
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we have abandoned further interest in substitute skeletal fixation
systems.
The skeletal fixation of limb prostheses, however, remains an
achievable goal. In spite of the failures with the transverse suspension
system, further work in this area has continued. We have had one
successful application of a connect and disconnect system for an upper
extremity prosthesis using an intramedullary device. We believe that
we now have sufficiently understood principles so that a clinically
reliable prosthetic fixation system is feasible.
CASE HISTORIES
Case A is a sixty-eight year-old male who has had diabetes five
years and a right below knee amputation approximately five years ago.
The patient fell out of a wheelchair two weeks previously and suffered
a fracture of the right upper femur trochanteric region. The patient
required traction to the right stump to hold the fracture reduced.
On March 22, 1972 surgery was performed. A 3/16 inch smooth
Steinmann pin was inserted through the right tibia posterior to the
tibial tubercle. A medial side insertion of percutaneous interface
seal buttons (silastic-dacron-carbon) was made. The lateral side was
treated as usual - a traction pin through the skin.
Removal of tibial traction pin and percutaneous button with
excisional biopsy of surrounding skin was performed. Bony overgrowth
at the right tibular tip was removed to make a better prosthetic fit.
Preoperative course - all wounds healed per primus (4/20/72).
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Case B is a 26 year-old male with a history of seizure disorder.
He is a triple amputee (right high above elbow, right hip disarticulation,
left below knee amputation), who uses left below knee prosthesis for
wheelchair locomotion. He has difficulty with suspension of the left
prosthesis.
Patient had surgery April 20, 1972 for the insertion of percutaneous
endoskeletal fixation tube in proximal left tibia. Implantation of the
silastic-dacron-carbon device at medial and lateral projections of tube
required deep implantation adjacent to periosteum. Wounds
were slow to heal because of deep placement. The wound was well healed
around the carbon. (Figures 2, 3, 4 and 5)
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Figure 2
Silastic carbon device coming through the skin soon after surgery.
Figure 3
Transcortical Device
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Figure 4
Transparent socket with pylon for definitive prosthesis, suspended
by carbon skeletal fixation device
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Figure 5
Closeup of transparent socket with pylon for definitive prosthesis,
suspended by carbon skeletal fixation device.
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The patient had removal of percutaneous endoskeletal fixation tube
and silastic dacron carbon devices at medial and lateral sides on
August 24, 1972 due to infection around the tube. It should be noted
that the carbon devices remained free from infection.
In March, 1973 the patient had two carbon electrodes placed over
the muscles of his left below the knee stump. A stimulation program
was begun to enlarge the muscles in his stump to help suspend a
prosthesis. However, due to the precarious position of the buttons,
subject to much physical trauma, the buttons were removed August 5, 1973.
At the time of removal, there was no sign of tissue inflammation and
tissue sections are pending. Currently, the patient is being considered
for a skeletal attachment device.
Case C is a 46 year-old female. The reason for the skeletal
fixation device was previous severe burns of the left arm with high left
arm amputation at axilla level. Due to the short stump and grafts over
the skin burn about the left shoulder, the patient was unable to wear
any upper limb prosthesis.
Insertion of percutaneous endoskeletal fixation tube through the
left humerus stump just below surgical neck was made April 27, 1972.
Two skin interface seal buttons were inserted: the anterior was
silastic-dacron under a carbon collar and the posterior was polyurethane.
(Figure 6)
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Figure 6
Anterior - Silastic-dacron under carbon collar
Posterior - Polyurethane
Both wounds healed initially.
On September 14, 1972 the polyurethane percutaneous implant was
removed and replaced with a bioCarbon percutaneous implant due to
infection and drainage on the posterior side with the polyurethane.
The wounds healed. (Figures 7, 8, 9, 10)
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Figure 7
Anterior - Silastic-dacron under carbon collar.
Posterior - Polyurethane removed and replaced with carbon collar.
Figure 8
X-ray skeletal fixation device through humerus.
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Figure 9
Transparent socket fitted to stump for definitive prosthesis, suspended
by carbon skeletal fixation device
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Figure 10
Definitive prosthesis (using transparent socket) covered with cosmetic
glove.
Since the patient's surgeries, she has been seen on an outpatient
basis. The patient was not wearing the prosthesis because of discomfort
around the pin deep in the bone. When the patient was seen in clinic,
it was determined that infection was present around the bone portion of
the implant. X-rays confirmed this. It is a significant fact that the
carbon interface at the skin was free of infection and inflammation.
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However, removal of the devices was necessary in January 1973, carried
out with subsequent complete healing of the skin.
Case D. In March 1971, a volunteer had a carbon device implanted
in his arm. The device has remained free of infection to date. (Figure 11)
In mid-January 1973, a volunteer had a bioSnap implanted over his
peroneal nerve to evaluate the use of this device in functional neuro-
muscular stimulation.(Figure 12) Later, a second device was implanted
overlying the peroneal nerve just anterior to the neck of the fibula.
Its purpose is to test the efficiency of stimulating the dorsiflexion
musculature of the right foot for correction of drop foot secondary
to upper motor neuron disease through a carbon device.
Although the skin interface has not been a problem, the mode of
energy transmission is not well understood and, at this time, stimulation
through the device is no less painful than with surface stimulators.
The only advantage at present is convenience of electrode placement.
At the present time, we feel that improved design of electrodes can
correct this phase of the problem.
The button on the left leg remains infection-free and functioning
well. There was slight infection present in the right leg, which has
since cleared. The only residual is that the subcutaneous portion of
the button is partially exposed. Hopefully, epithelization will solve
this problem. Again, the ability of carbon to resist infection has
been demonstrated.
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Figure 11
Implant of carbon device in arm. Infection-free (3/71 - 8/73)
Figure 12
BioSnap implanted over peroneal nerve C1/15/73 - 8/73) Infection-free.
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Case E is a 55 year-old female with severe arachnoiditis following
multiple surgical procedures on her thoracic and lumbar spine. She
was originally admitted to the Problem Back Treatment Center and
implantation of a dorsal column stimulator was anticipated. After a
thorough workup and investigation of her anatomic as well as psychological
status, it was apparent that she had true anatomic sources of pain.
Empirically, it was found that various sites on her skin acted as trigger
points and when electrically stimulated with a cutaneous stimulating
device, consistent and persistent relief of her pain could be attained.
Because maintaining moist surface electrodes was extremely inconvenient,
especially in the upper thoracic spine area, two carbon buttons were
implanted under local anesthesia over the trigger point sites. These
were then connected by wire to the transistor radio size cutaneous
stimulating device. The patient, at this point, was tolerating the
stimulation very well and no longer needed the narcotics on which she
was admitted. (Figure 13, 14, 15)
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Figure 13
Button - 4 Weeks after implant
Figure 14
Button - 6 weeks post-implant
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Figure 15
Both devices at 4 weeks and 6 weeks, respectively
In January 1973, the patient had difficulty with connectors to
the carbon buttons. Several designs were tried, however none made
a satisfactory connection and,presumably because of continuous manipulation
and irritation from the device and the wires going to it,some drainage
and infection developed around the button. All stimulation was therefore
discontinued for a period of one week when, as a temporary solution,
connection to the device was made externally.
In March 1973, the patient reported that the upper button had been
subjected to a significant trauma which almost tore it loose and a
slight infection had been present for about two weeks. The button was
watched closely for several months, and it then became necessary to
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replace it with a type I device for pain control. The patient is
scheduled for surgery August 23, 1973.
It should be noted that the patient states she could "not live
without her stimulation on the lower button."
Case F is a 40 year-old male. The patient was in a deep coma,
and, because of severe spasticity, developed flexion contractures of
both upper and lower extremities. (Figure 16)
Figure 16
Patient with flexion contractures before implant
This in turn led to the development of pressure sores and made
the patient a nursing problem. Release of his contracted knees could
be carried out surgically, however, through stimulation of muscles in
his leg, the effect of surgical releases could be improved and maintained.
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In December 1972, a bioCarbon device which allowed connection of
electrodes to his femoral nerves was implanted. Since that time, his
contractures were almost completely worked out, and the carbon device
continued to remain clean and infection-free. (Figure 17, 18)
Figure 17
2 Months after stimulator program was begun
Pressure sores healed eliminating the nursing problem
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Figure 18
11 Weeks Postoperative
Three months postoperative, the device continued to work well.
The carbon proved to be very effective and the patient's contractures
had essentially been pulled out by chronic neuromuscular stimulation.
The device was removed on March 8, 1973 because the flexion contracture
of his right leg had been pulled out. At the time of removal, the
carbon collar was free from infection and the device was working well.
Case G is a 28 year-old male with a head injury of unknown etiology.
The patient had a spastic right upper extremity which was developing a
flexion contracture at the elbow. In February 1973 he had a phenol
block in the nerve to the elbow flexors and two bioSnap-type electrodes
were implanted over the motor points of the elbow extensors for the
purpose of exercising the arm. (Figure 19, 20)
A stimulation program was begun two weeks postoperatively of the tricep
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to overcome the spasticity of the elbow flexors.
Figure 19
Implant of carbon bioSnaps C2/22/73) - stimulation program begun
5/22/73 for release of flexion contractures.
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Figure 20
BioSnap devices in place 5 months postoperatively - infection-free
After sixteen weeks of continuous muscle stimulation, the patient's
program was terminated because the electrodes were no longer needed
functionally for the patient's rehabilitation program.
Case H is a 62 year-old male with tuberculous meningitis and
contractures. (Figure 21) The left contracture was of such a degree
that surgical release was necessary- A type 4 device was implanted
around the patient's left femoral nerve. Simultaneously, two type I
devices were implanted in the skin over the femoral nerve. A comparison
could then be made of stimulation through each of these electrode
systems.
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Figure 21
Patient shown with flexion contracture
Three months postoperatively the carbon collar around the wire
to his femoral nerve was functioning satisfactorily. There was
good healing around the device and the two cutaneous electrodes over
his femoral nerves were in satisfactory condition. However, stimulation
through the electrodes did not produce adequate contraction of the leg
and were therefore not being used.
The devices were removed May 10, 1973 because the patient had
received the maximum benefit from neuroelectric stimulation. The
patient is now able to sit in a wheelchair and his decubitis ulcers
are virtually healed.
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Figure 22
Carbon implant shown - infection-free.
Case I is a 50 year-old female that had sustained a severe stroke
and had flexion contractures of both lower extremities. A totally
implanted electrode on one side had been used to stiumulate her knee
extensors and pull out the contractures. In order to compare the
cutaneous stimulation with the totally implanted device, two buttons
were placed in the skin over the femoral nerve in March 1973. (Figure 23, 24)
Stimulation was postponed because of problems with the stimulator
and the connecting wires. The buttons, however, continued to heal well.
Two months postoperatively stimulation was attempted through the buttons,
however,it was apparent that the current necessary to activate the
femoral nerve was painful. This suggests that further design modifications
will have to be made in the carbon device to be practical in this
application.
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Figure 23
BioSnaps implanted 3/22/73 - stimulation begun 5/2/73
Figure 24
Devices in place - infection-free
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Case J is a 58 year-old male stroke victim with severe spastic
contractures of both lower extremities. Surgical hip and knee releases
were performed, and on April 1973 a carbon-type 4 device was placed
over the right and left femoral nerves. The patient also had six type I
buttons to surface stimulate the nerves. (See appendix for complete
description of approaches using carbon for neuroelectric stimulation
page 8 and 9.) For reasons unknown, the implant on the right side did
not function well. The left neuro implant functioned quite well. It
was felt that the left leg was somewhat stronger secondary to stimulation.
The type I buttons also produced good muscle action. All of the
buttons have been removed in accordance with the protocol of the femoral
nerve program. We are awaiting tissue sections.
Case K is a 25 year-old female. On May 31, 1973, two devices were
implanted because of severe hip and knee flexion contractures. A
stimulation program was begun one week postoperatively.
On July 20, 1973 torque testing of the knee extensors was carried
out and the torque generated by stimulating the myoelectrode versus
the neuroelectrode was compared. Only a slight difference was found,
indicating that perhaps only a myoelectrode is necessary for clinical
application. The myoelectrode requires much less surgery, implying
broader clinical application.
To date, both buttons of type 3 and 4 are continuing to be infection-
free and functioning well.
Case L, a 33 year-old female, had two electrodes implanted over
pain points in the left lumbar area on May 29, 1973. A stimulation
program was begun, but was limited because of infection. On July 3, 1973
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(six weeks after implantation), the devices were removed because of
continued pain from mechanical irritation. The difficulty was in the
placement of the electrodes rather than the electrodes themselves.
Case M. a 50 year-old female, had two type I carbon devices
implanted June 6, 1973 to facilitate electrical stimulation to block
pain. The patient has undergone a program of stimulation which has
been successful. The devices continue to be totally free of infection
and functioning well.
Case N is a 71 year-old male and a triple amputee. In May 1973,
the patient had a intramedullary device implanted for a direct skeletal
attachment of a limb prosthesis. The device will allow the attachment
of a below elbow prosthesis which is necessary for self-care activities
and walking (to hold a crutch). (Figure 25, 26)
Figure 25
Connector system for skeletal fixation of limb prosthesis. Lower portion
indicates carbon collar fastened to implanted receiver system. Superior
portion indicates prosthetic connector system.
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Two months postoperative, the carbon button at the end of the
skeletal attachment device had the skin retract from the medial surface
exposing the entire medial flange. The patient underwent surgery to
advance the flaps around the carbon button. Prior to and postoperative,
there was no sign of infection.
The patient was fitted with a Fidelity-type electric below elbow
hand. The prosthesis appears to be very functional and a cosmetic
cover will be attached. (Figure 27)
Figure 26
Connector system on patient (71-year-old diabetic with Syme's and
above-knee amputation as well).
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Figure 27
Prosthesis in place before fabrication of cosmetic cover.
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SUMMARY
The goals of this small pilot project determining feasible medical
application of unique bioCarbon have been achieved. The clinical
application of these carbons to solve human problems has been demonstrated.
By taking advantage of the unique characteristic of traversing the
skin without threat of infection, practical clinical applications of
medical engineering technology have been demonstrated.
But the demonstration of successful application of carbon technology
to human medical problems has created new problems which need solution
before general clinical utilization of these materials are available.
First, in terms of the material itself, questions remain. Is pyrolytic
carbon different from vitreous carbon in terms of biocompatibility?
To answer the question, a series of patients must have devices of
similar physical design and dimensions implanted side by side to note
any difference in reaction between the two. Although this plan was
originally to be determined by the skeletal traction system, it was
not carried out because of the lack of general application of the carbon
collar skeletal traction. Smaller devices of the bioSnap-type design,
which would be applicable for neuro or myoelectrical stimulation, are
more appropriate test devices.
Another unresolved problem concerns the nature of electrical
fields in relation to a carbon implant. Would myo-electrical stimulation
be improved if only a portion of the implant were electrically active,
the rest functioning purely as a tissue interface? Would less energy,
and thus less potential pain, result from an electrode of this design?
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Only human trial can evaluate this factor because sensation is a variable
that cannot be excluded.
One of the most significant engineering problems that remains is
that of the electrical connect-disconnect system interface with the carbon.
Although the carbon has demonstrated itself to be highly compatible with
tissues, building a reliable connector system into the carbon shell
remains a considerable engineering challenge. Today, we do.not have a reliable
system and feel that we must permanently cement the connectors to the
carbon for clinical application to have a competent electrical stimulation
system. If the neuroelectric connector system is to be clinically
applicable, the engineering of these connectors must be accomplished so
that a reliable, inexpensive and serviceable system can be developed.
The drawing in the accompanying paper suggests only one solution, many
others are probably feasible. In this area, however, without a reliable
connector system all the advantages of infection-free percutaneous passage
will not be available for clinical application.
With the demonstration of the unusual biological acceptability of
pure carbons, and with a recognition of their potential as electrodes,
other utilization of these materials is worthy of consideration. Placement
of electrodes indefinitely within muscle or nerve seems potentially
feasible if these electrodes cause no local tissue reaction. If we can
demonstrate this to be a fact, many applications in the area of chronic
muscle stimulation seem reasonable. As an example, an implanted electrode
could be placed within the muscles of an adolescent girl with curvature
of the spine aind under chronic stimulation of the appropriate muscles
effect straightening of the curvature. (This has already been demonstrated
Medical Applications of Unique BioCarbons Page 35.
in animals elsewhere.) Retained carbon electrodes could cause new bone
formation at the site of a nonunion fracture. Once the bone has formed
about the electrode to heal the fracture, it can be left in place indef-
initely. (Fracture healing using a very minimal level of direct current
and stainless steel electrodes has already been demonstrated in animals
and humans. The electrode systems are current limitations of this method.)
Further experimental studies regarding the electrical characteristics
and configuration of carbon electrodes are necessary.
The feasibility of prosthetic connector systems has likewise
been demonstrated. The pilot problem achieved what had never before
been considered possible; a limb prosthesis fixed to a bone that can be
connected and disconnected at the will of the amputee. The engineering
of this connector system, however, requires a great deal more sophistication
before it will be available for clinical application. Nonetheless, it
is quite reasonable to expect that prosthetic fittings of the future will
utilize the system once standardization of specifications and attachment
strings become available.
In summary, this small pilot study has well demonstrated the
feasibility of infection-free passage through the skin. It has shown
that vitreaus carbon is an unusual material with unique biocompatibility
potential. However, to take full advantage of this material, we must
develop considerably more experience with engineering interface to carbon.
Neuroelectric connector systems and prosthetic connect-disconnect systems
are such examples.
Page 36
GLOSSARY OF TERMS
1. Bioacceptability, Biocompatible, Biostable. Refers to the ability of
a material or process to be placed within a biological environment
and remain there without invoking a rejection or reaction from the
biological environment.
2. Bioelectric. Refers to electrical energy within a biological environment
applied to the outside.
3. Button. A carbon device of specific shape and dimension as shown in
Figure 13.
4. Contracture. Deformity of a joint because of shortening of tissues on
one side frequently seen in strokes and head injuries.
5. Conventional Socket. The cup-shaped portion of a typical artificial
limb into which the stump is placed.
6. Device. The total unit with all attached wires and the connectors to it.
7. Dorsal Column Stimulator. An electronic stimulator produced by the
Medtronic Corporation used to relieve pain by applying direct stimulation
to the spinal cord. The electrodes from the stimulator lie within the
spinal canal and the present system uses a stimulator connected to an
antenna which activates a passive receiver implanted under the skin
which then connects with the electrode. The coupling is made via two
induction coils.
8. Endoskeletal. Refers to the interior portion of elements of the skeletal
system, i.e., the medullary canal of a bone or the joint space.
9. General Anesthesia vs. Local Anesthesia. General anesthesia requires
putting the patient to sleep and carries with it more risk to the patient
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than local anesthesia, which merely involves numbing the area around
the place where an incision will be made. The former requires more
equipment and more personnel than the latter.
10. Limb Prosthesis. An artificial arm or leg.
11. Medullary Canal. The spongy internal portion of a bone filled with fat,
blood and thin wafers of bone.
12. Motor point. A point on the skin over a muscle at which stimulation can
be applied to activate the muscle and produce a contraction.
13. Myoelectrode. An electrode place into the body of a muscle.
14. Neuroelectrode. An electrode wrapped around a nerve.
15. Neuroelectric Stimulation. Passing electric current into a nerve in order
to activate that nerve and reproduce the physiological effect of such
nerve activation.
16. Percutaneous Passage. Bringing a material through the skin as opposed
to transcutaneous, which implies going across the skin without violating
it.
17. Peroneal Nerve. The nerve lying below the knee on the outer aspect of
the lower leg which activates the muscles of the toes and foot causing
the toes and foot to move away from the floor toward the head.
18. Shell. The portion of a carbon device which is made of carbon and
interfaces with the skin.
19. Skeletal Fixation. Direct attachment of external prosthesis to a
long bone by use of an intramedullary rod.
20. Skeletal Interface. Area of direct appostion between bone and a
material.
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21. Skeletal Suspension. Hanging something, such as an artificial limb,
directly from the bone.
22. Skeletal Traction. Traction applied upon the long bones by means of
a metal rod, carbon rod, etc.
23. Transparent Socket. A clear socket used as a visual method employed by
prosthetists to determine the intimacy of the stump-socket relationship.
